(2-(Tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)boronic acid, 98%, 100mg

(4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid, 1g

1,3-Diiodopropane (stabilised with Copper), 99.0%, 25g

Methyl 2-hydroxy-3-methoxy-3,3-diphenylpropanoate, 95.0%, 10g

5-AMINO-2-CHLOROPYRIMIDINE-4-CARBOXAMIDE, 95%, 100mg

Benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate, 98%, 5g

2-Fluoropyridine, 98.0%, 250g

Analytical and precision scale Entris® II series Models with internal adjustment, factory calibrated, 0.001 g, 420 g, BCE423i-1CEU (W)

(R)-3-(Aminomethyl)-1-(tert-butoxycarbonyl)pyrrolidine>98.0%(GC)(T)500mg

1-methyl-3-(trifluoromethyl)-1H-pyrazole-5-carbaldehyde, 95.0%, 100mg

3-Bromo-5-methoxybenzene-1-sulfonyl chloride, 95%, 100mg

4-Bromo-3-chloro-2-fluoroaniline, 98.0%, 25g

(S)-Octahydropyrrolo[1,2-a]pyrazinedihydrochloride, 95.0%, 500mg